Skip to main content

ABBV-552

ABBV-552 is an SV2A modulator which is being evaluated to target nerve terminals to enhance synaptic efficiency. The mechanism is being evaluated for the potential treatment of cognitive impairment and other symptoms associated with a range of neuropsychiatric and neurodegenerative disorders.

Type of Molecule

Small Molecule

Target

SV2A

Product Type

New Indication
Potential Indication Region Phase (1, 2, 3, Submitted)
Alzheimer's Disease n/a
Phase 1